EndoQuest Robotics has submitted an IDE application for its pivotal colorectal clinical study.The study, called PARADIGM, will assess the Endoluminal Surgical (ELS) System.The company plans to conduct the study at five leading U.S. healthcare facilities.The IDE submission is subject to FDA review and approval.